Any treatment strategy that leads to an improvement in the Klotho levels by augmentation with external Klotho or uplifts the levels of endogenous Klotho manufacturing can be labeled a new novel therapy in renal disorders such as CKD [54]. The gene discussed is KL; the disease is chronic kidney disease.